Bull Hedging
  • Politics
  • Stocks
  • Business
  • Investing
  • Politics
  • Stocks
  • Business
  • Investing

Bull Hedging

Politics

Obama reacts to Biden diagnosis: ‘Nobody has done more to find breakthrough treatments for cancer…than Joe’

by admin May 19, 2025
May 19, 2025
Obama reacts to Biden diagnosis: ‘Nobody has done more to find breakthrough treatments for cancer…than Joe’

Former President Barack Obama, former President Bill Clinton, and President Donald Trump have each commented on the grim news of President Joe Biden’s cancer diagnosis.

‘Michelle and I are thinking of the entire Biden family. Nobody has done more to find breakthrough treatments for cancer in all its forms than Joe, and I am certain he will fight this challenge with his trademark resolve and grace. We pray for a fast and full recovery,’ Obama noted in posts on social media.

Biden served as vice president during Obama’s White House tenure from early 2009 through early 2017.

He was diagnosed with prostate cancer last week, according to a statement his personal office released on Sunday.

‘Last week, President Joe Biden was seen for a new finding of a prostate nodule after experiencing increasing urinary symptoms. On Friday, he was diagnosed with prostate cancer, characterized by a Gleason score of 9 (Grade Group 5) with metastasis to the bone. While this represents a more aggressive form of the disease, the cancer appears to be hormone-sensitive which allows for effective management. The President and his family are reviewing treatment options with his physicians,’ the statement noted.

President Donald Trump also commented on the news.

‘Melania and I are saddened to hear about Joe Biden’s recent medical diagnosis. We extend our warmest and best wishes to Jill and the family, and we wish Joe a fast and successful recovery,’ he noted in a post on Truth Social. 

The Clintons both commented as well.

‘My friend Joe Biden’s always been a fighter. Hillary and I are rooting for him and are keeping him, Jill, and the entire family in our thoughts,’ former President Bill Clinton noted.

‘I’m thinking of the Bidens as they take on cancer, a disease they’ve done so much to try to spare other families from. Wishing you a speedy, full recovery,’ former Secretary of State Hillary Clinton, who lost the 2016 presidential election to Donald Trump, said in social media posts.

Biden, who left office earlier this year on Jan. 20, is 82 years old. 

Fox News’ Peter Doocy contributed to this report

This post appeared first on FOX NEWS

previous post
Trump reshapes US foreign policy with wildly successful, business-first Middle East trip
next post
Iran foreign minister vows nuclear enrichment will continue ‘with or without a deal’

Related Posts

Pentagon deputy chief of staff is second Hegseth...

April 16, 2025

National Security Agency Director Gen. Haugh fired, civilian...

April 4, 2025

New poll details Americans’ views on Trump and...

March 14, 2025

Trump’s MAGA imprint on GOP strong now, but...

April 27, 2025

GOP outperformed Dems on voter registration in key...

May 22, 2025

President Trump says ‘we will have relations with...

February 8, 2025

Trump world fires back at Politico over report...

April 25, 2025

Federal judge orders halt to Trump admin’s CFPB...

April 19, 2025

House Freedom Caucus heading to White House after...

May 22, 2025

Trump signs executive order making English official language...

March 2, 2025

Recent Posts

  • S&P 500 Slide Explained: What Past Price Action Reveals About Market Dips
  • Applying Key Ratios to the Broader Market Surge: Are We at the Threshold of a New Trend?
  • Moving from Thrust Signals to a Bull Market
  • What Happens When the S&P 500 Breaks Below Gap Support?
  • Automate Your Scans with Ease! Sample Scan Library + Scheduled Scans Walkthrough

Recent Comments

No comments to show.

About Us

About Us

Design Magazine

Welcome to Design Magazine. Follow us for daily & updated design tips, guide and knowledge.

Stay Connect

Facebook Twitter Instagram Pinterest Youtube Email

Recent Posts

  • S&P 500 Slide Explained: What Past Price Action Reveals About Market Dips

    May 24, 2025
  • Applying Key Ratios to the Broader Market Surge: Are We at the Threshold of a New Trend?

    May 24, 2025
  • Moving from Thrust Signals to a Bull Market

    May 24, 2025
  • What Happens When the S&P 500 Breaks Below Gap Support?

    May 24, 2025
  • Automate Your Scans with Ease! Sample Scan Library + Scheduled Scans Walkthrough

    May 24, 2025
  • 3 Stocks to Watch While Everyone’s Staring at NVIDIA

    May 24, 2025

Editors’ Picks

  • 1

    Small Caps are Set to Skyrocket in 2025—Here’s What You Need to Know

    December 12, 2024
  • 2

    Trump leaves China guessing what his next move is with unusual inauguration invitation

    December 15, 2024
  • 3

    Uranium Price Forecast: Top Trends That Will Affect Uranium in 2025

    December 19, 2024
  • 4

    Ad revenue should stabilize for media companies in 2025 — if they have sports

    December 31, 2024
  • 5

    Trudeau declares himself ‘proud feminist’ after lamenting Harris loss to Trump as setback for women

    December 13, 2024
  • 6

    Zinc Stocks: 4 Biggest Canadian Companies in 2025

    January 15, 2025
  • 7

    Lead Price Forecast: Top Trends for Lead in 2025

    January 11, 2025
Promotion Image

banner

Categories

  • Business (368)
  • Investing (1,188)
  • Politics (1,482)
  • Stocks (485)
  • About us
  • Contacts
  • Privacy Policy
  • Terms and Conditions
  • Email Whitelisting

Disclaimer: bullhedging.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


Copyright © 2025 bullhedging.com | All Rights Reserved